申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2011036128A1
                            
                            
                                公开(公告)日:2011-03-31
                            
                            The invention discloses 1-N-substituted-6-(hetero)aryl-1H-thieno[3,2-d]pyrimidin-4-one derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined herein that inhibit Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.